Balance Sheet
Accumulated ExpensesAssetsCash & Current InvestmentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Cresco Labs (CRLBF) Common Equity (2019 - 2025)

Historic Common Equity for Cresco Labs (CRLBF) over the last 7 years, with Q3 2025 value amounting to $340.2 million.

  • Cresco Labs' Common Equity fell 689.61% to $340.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $340.2 million, marking a year-over-year decrease of 689.61%. This contributed to the annual value of $388.2 million for FY2024, which is 2323.87% down from last year.
  • According to the latest figures from Q3 2025, Cresco Labs' Common Equity is $340.2 million, which was down 689.61% from $360.9 million recorded in Q2 2025.
  • In the past 5 years, Cresco Labs' Common Equity registered a high of $783.6 million during Q2 2022, and its lowest value of $340.2 million during Q3 2025.
  • Over the past 5 years, Cresco Labs' median Common Equity value was $526.3 million (recorded in 2023), while the average stood at $542.0 million.
  • As far as peak fluctuations go, Cresco Labs' Common Equity surged by 5965.66% in 2021, and later plummeted by 4479.7% in 2023.
  • Over the past 5 years, Cresco Labs' Common Equity (Quarter) stood at $755.6 million in 2021, then dropped by 22.22% to $587.7 million in 2022, then decreased by 13.95% to $505.7 million in 2023, then decreased by 23.24% to $388.2 million in 2024, then dropped by 12.37% to $340.2 million in 2025.
  • Its Common Equity was $340.2 million in Q3 2025, compared to $360.9 million in Q2 2025 and $375.6 million in Q1 2025.